Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous immunoglobulin (Subcuvia) as adjunct during Prednisolone tapering in active systemic lupus erythematosus
2006-004892-36Phase 2Active
- Sponsor
- Department of Rheumatology, Skåne University Hospital
- Start
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of subcuvia in systemic lupus erythematosus (SLE) (2 arms), sponsored by Department of Rheumatology, Skåne University Hospital. Started Feb 2007; status: active.
02
Drugs
subcuvia
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on 2006-004892-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004892-36.